Author

N. A. Moatamed

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

A. Ioannidis· 1 shared A. Soragni· 1 shared B. Tofig· 1 shared D. Elashoff· 1 shared F. Pajonk· 1 shared J. Huang· 1 shared J. J. Hong· 1 shared K. Bhat· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ioannidis

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tumor Necrosis Factor Receptor Signaling Modulates Carcinogenesis in a Mouse Model of Breast Cancer

L. He, K. Bhat, S. Duhacheck-Muggy, A. Ioannidis, L. Zhang, N. T. Nguyen, N. A. Moatamed, F. Pajonk

This study shows that reducing TNFR2 signaling in mice increases breast cancer incidence and aggressiveness, suggesting TNFR2 agonists could help prevent breast cancer in high-risk populations.

bioRxiv · Mar 12, 2020Cancer Biology

A simple high-throughput approach identifies actionable drug responses in patient-derived tumor organoids

N. Phan, J. J. Hong, B. Tofig, M. Mapua, D. Elashoff, N. A. Moatamed, J. Huang, S. Memarzadeh, R. Damoiseaux, A. Soragni

This paper introduces a high-throughput method for drug screening using tumor organoids and identifies effective drugs for ovarian cancer within a week of surgery.

bioRxiv · Aug 13, 2018Cancer Biology